142 related articles for article (PubMed ID: 37843679)
1. Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy.
Zheng M; Wang S; Zhu Y; Wan H
Support Care Cancer; 2023 Oct; 31(12):630. PubMed ID: 37843679
[TBL] [Abstract][Full Text] [Related]
2. A qualitative exploration of fear of progression in patients with nasopharyngeal carcinoma treated with proton and heavy ion therapy.
Zheng M; Wang S; Zhu Y; Wan H
Support Care Cancer; 2023 Oct; 31(12):622. PubMed ID: 37815579
[TBL] [Abstract][Full Text] [Related]
3. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in patients with nasopharyngeal carcinoma receiving IMRT vs IMPT: a multicenter prospective longitudinal study.
Chung CF; Huang BS; Wang YM; Huang YT; Chen SC
Support Care Cancer; 2024 Mar; 32(3):203. PubMed ID: 38430411
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the Fear of Progression Questionnaire for parents of children with cancer (FoP-Q-SF/PR).
Clever K; Schepper F; Pletschko T; Herschbach P; Christiansen H; Martini J
J Psychosom Res; 2018 Apr; 107():7-13. PubMed ID: 29502766
[TBL] [Abstract][Full Text] [Related]
7. Psychometric Properties of the Fear of Progression Questionnaire for Children (FoP-Q-SF/C).
Luz JK; Martini J; Clever K; Herschbach P; Christiansen H; Schepper F
Klin Padiatr; 2020 May; 232(3):136-142. PubMed ID: 32193886
[TBL] [Abstract][Full Text] [Related]
8. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
10. Fear of progression and its associated factors in parents of children undergoing cancer treatment: A cross-sectional study.
Yang Y; Zhang Y; Liang L; Liao X; Meng J; Cai R; Ye H; Hu J; He X; Shi L
Psychooncology; 2022 Oct; 31(10):1737-1744. PubMed ID: 36073576
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of two group therapies to reduce fear of progression in cancer patients.
Herschbach P; Book K; Dinkel A; Berg P; Waadt S; Duran G; Engst-Hastreiter U; Henrich G
Support Care Cancer; 2010 Apr; 18(4):471-9. PubMed ID: 19865833
[TBL] [Abstract][Full Text] [Related]
12. OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer.
Frangou E; Bertelli G; Love S; Mackean MJ; Glasspool RM; Fotopoulou C; Cook A; Nicum S; Lord R; Ferguson M; Roux RL; Martinez M; Butcher C; Hulbert-Williams N; Howells L; Blagden SP
Gynecol Oncol; 2021 Aug; 162(2):431-439. PubMed ID: 34059348
[TBL] [Abstract][Full Text] [Related]
13. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.
Melchior H; Büscher C; Thorenz A; Grochocka A; Koch U; Watzke B
Psychooncology; 2013 Jan; 22(1):39-45. PubMed ID: 21898655
[TBL] [Abstract][Full Text] [Related]
14. New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center.
Hefner J; Berberich S; Lanvers E; Sanning M; Steimer AK; Kunzmann V
Patient Prefer Adherence; 2017; 11():1907-1914. PubMed ID: 29180853
[TBL] [Abstract][Full Text] [Related]
15. [Fear of progression in parents of children with cancer: adaptation of the Fear of Progression Questionnaire and correlates].
Schepper F; Abel K; Herschbach P; Christiansen H; Mehnert A; Martini J
Klin Padiatr; 2015 May; 227(3):151-6. PubMed ID: 25811743
[TBL] [Abstract][Full Text] [Related]
16. [Expression of pepsin in nasopharyngeal carcinoma and its correlation with quality of life after radiotherapy].
Zhang T; Yu GD; Jin FW; Zhou J; Tang ZP; Xian ZM; Wu Z
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 57(6):699-705. PubMed ID: 35725312
[No Abstract] [Full Text] [Related]
17. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
18. Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long-term cancer survivors.
Götze H; Taubenheim S; Dietz A; Lordick F; Mehnert-Theuerkauf A
Psychooncology; 2019 Oct; 28(10):2033-2041. PubMed ID: 31364222
[TBL] [Abstract][Full Text] [Related]
19. Psychometric validation of the fear of progression questionnaire-short form in acute pancreatitis patients.
Ma S; Yang X; Xiang S; Lu G; Gong W; Chen W
Heliyon; 2023 Aug; 9(8):e19060. PubMed ID: 37654456
[TBL] [Abstract][Full Text] [Related]
20. Fear of disease progression and relevant correlates in acute leukemia patients prior to allogeneic hematopoietic stem cell transplantation.
Thiele S; Goebel S; Kröger N; Pedersen A
Psychooncology; 2020 Aug; 29(8):1248-1254. PubMed ID: 32323380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
